News Apr 30, 2024
Porton 2023 ESG Report
STRATEGIC EXPANSIONS FOR CUSTOMER-CENTRIC & GLOBAL SOLUTIONS
News Apr 19, 2024
Upcoming Porton Shows in Europe and the USA：Shaping Our Future Together
STRATEGIC EXPANSIONS FOR CUSTOMER-CENTRIC & GLOBAL SOLUTIONS
News Mar 28, 2024
Porton Makes Debut at DCAT Week 2024 to Jointly Promote Industry Development
STRATEGIC EXPANSIONS FOR CUSTOMER-CENTRIC & GLOBAL SOLUTIONS
News Mar 08, 2024
Join Our Founder and CEO @ DCAT Week
STRATEGIC EXPANSIONS FOR CUSTOMER-CENTRIC & GLOBAL SOLUTIONS
News Mar 02, 2024
Porton Pharma Solutions Joined the SBTi to Drive Climate Action
Porton announces the opening of a new drug development facility adjacent to its existing API synthesis facility in New Jersey, USA. (September 5, 2023 – CRANBURY, NJ)
News Jan 05, 2024
Farewell to 2023, and WE are Sailing forward to 2024
Porton announces the opening of a new drug development facility adjacent to its existing API synthesis facility in New Jersey, USA. (September 5, 2023 – CRANBURY, NJ)
News Sep 28, 2023
The Pharma Crystallization Summit (PCS) is held annually to bring together developers of new medicines with crystallization challenges and the crystallization experts (solution providers) in the industry and academia.
Porton announces the opening of a new drug development facility adjacent to its existing API synthesis facility in New Jersey, USA. (September 5, 2023 – CRANBURY, NJ)
News Sep 20, 2023
Porton Gets Improved in the 2023 S&P Global ESG Score
Porton announces the opening of a new drug development facility adjacent to its existing API synthesis facility in New Jersey, USA. (September 5, 2023 – CRANBURY, NJ)
News Sep 13, 2023
Porton Pharma Solutions Announces New Flagship Facility Offering Integrated API Crystallization and Drug Product Development Services
Porton announces the opening of a new drug development facility adjacent to its existing API synthesis facility in New Jersey, USA. (September 5, 2023 – CRANBURY, NJ)
